Le Fei Sun
Directeur/Membre du Conseil chez Biotheus, Inc.
Profil
Le Fei Sun is currently the Managing Director at General Atlantic Asia Ltd., the Director at Hong Kong Asia Medical Holding Co. Ltd., and the Director at Biotheus, Inc. Previously, he held positions as the Non-Executive Director at HUTCHMED (China) Ltd., the Director at Adagene, Inc., the Non-Executive Director at Ocumension Therapeutics, and the Director at Canbridge Pharmaceuticals, Inc. (United States).
He also worked as an Associate at OrbiMed Advisors LLC, a Principal at McKinsey & Co., Inc., and a Research Analyst at Credit Suisse (Hong Kong) Ltd.
Prior to that, he was a Founding Partner at Beijing Huatai Ruihe Healthcare Investment Fund LLP.
Dr. Sun obtained a doctorate degree from The Johns Hopkins University and completed his undergraduate studies at Tsinghua University.
He also received a graduate degree from The Johns Hopkins University School of Medicine.
Postes actifs de Le Fei Sun
| Sociétés | Poste | Début |
|---|---|---|
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Private Equity Investor | 01/05/2018 |
Hong Kong Asia Medical Holding Co. Ltd.
 Hong Kong Asia Medical Holding Co. Ltd. Medical/Nursing ServicesHealth Services Hong Kong Asia Medical Holding Co. Ltd. provides health care services. The company was founded in 1999 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | 01/11/2019 |
Biotheus, Inc.
 Biotheus, Inc. BiotechnologyHealth Technology Biotheus, Inc. is a biopharmaceutical company based in Zhuhai, China. The Chinese company aims to become a leading domestic biopharmaceutical company with a high-value product chain, strong innovation capabilities, and an experienced core team. It was founded in 2018 by Jun Wei Zeng, Xiao Lin Liu, and Zuo Yu Sun, with Xiao Lin Liu serving as the CEO. | Directeur/Membre du Conseil | - |
Anciens postes connus de Le Fei Sun
| Sociétés | Poste | Fin |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Directeur/Membre du Conseil | 13/07/2023 |
| ADAGENE INC. | Directeur/Membre du Conseil | 28/04/2023 |
| OCUMENSION THERAPEUTICS | Directeur/Membre du Conseil | 19/03/2021 |
| Beijing Huatai Ruihe Healthcare Investment Fund LLP | Corporate Officer/Principal | 01/04/2018 |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Directeur/Membre du Conseil | - |
Formation de Le Fei Sun
| The Johns Hopkins University | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ADAGENE INC. | Health Technology |
| OCUMENSION THERAPEUTICS | Health Technology |
| Entreprise privées | 8 |
|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Finance |
General Atlantic Asia Ltd.
General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Finance |
Hong Kong Asia Medical Holding Co. Ltd.
Hong Kong Asia Medical Holding Co. Ltd. Medical/Nursing ServicesHealth Services Hong Kong Asia Medical Holding Co. Ltd. provides health care services. The company was founded in 1999 and is headquartered in Hong Kong. | Health Services |
Biotheus, Inc.
Biotheus, Inc. BiotechnologyHealth Technology Biotheus, Inc. is a biopharmaceutical company based in Zhuhai, China. The Chinese company aims to become a leading domestic biopharmaceutical company with a high-value product chain, strong innovation capabilities, and an experienced core team. It was founded in 2018 by Jun Wei Zeng, Xiao Lin Liu, and Zuo Yu Sun, with Xiao Lin Liu serving as the CEO. | Health Technology |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
| Beijing Huatai Ruihe Healthcare Investment Fund LLP |